Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer (Q47385607)

15 January 2018

title

Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer (English)

1 reference

15 January 2018

1 reference

F Cornud

1 reference

15 January 2018

author name string

N B Delongchamps

1 reference

15 January 2018

F Beuvon

1 reference

15 January 2018

D Eiss

1 reference

15 January 2018

T Flam

1 reference

15 January 2018

N Muradyan

1 reference

15 January 2018

M Zerbib

1 reference

15 January 2018

M Peyromaure

1 reference

15 January 2018

publication date

22 March 2011

1 reference

15 January 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

15 January 2018

volume

1 reference

15 January 2018

issue

1 reference

15 January 2018

page(s)

232-237

1 reference

15 January 2018

Stage migration in clinically localized prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Functional magnetic resonance imaging in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Dynamic contrast enhanced MRI in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Saturation biopsy of the prostate: why saturation does not saturate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

A Streamlined Three-Dimensional Volume Estimation Method Accurately Classifies Prostate Tumors by Volume

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

[Quantitative dynamic MRI and localisation of non-palpable prostate cancer]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.9

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.9

1 reference

15 January 2018

1 reference

15 January 2018